Search Results - "The Journal of thoracic and cardiovascular surgery"

Refine Results
  1. 1

    Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial by Suzuki, Kenji, Saji, Hisashi, Aokage, Keiju, Watanabe, Shun-ichi, Okada, Morihito, Mizusawa, Junki, Nakajima, Ryu, Tsuboi, Masahiro, Nakamura, Shinichiro, Nakamura, Kenichi, Mitsudomi, Tetsuya, Asamura, Hisao

    “…No definitive comparisons of surgical morbidity between segmentectomy and lobectomy for non–small cell lung cancer have been reported. We conducted a…”
    Get full text
    Journal Article
  2. 2

    A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer by Suzuki, Kenji, Watanabe, Shun-ichi, Wakabayashi, Masashi, Saji, Hisashi, Aokage, Keiju, Moriya, Yasumitsu, Yoshino, Ichiro, Tsuboi, Masahiro, Nakamura, Shinichiro, Nakamura, Kenichi, Mitsudomi, Tetsuya, Asamura, Hisao

    “…The optimal mode of surgery for ground-glass opacity dominant peripheral lung cancer defined with thoracic thin-section computed tomography remains unknown. We…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Results of low-dose computed tomography as a regular health examination among Chinese hospital employees by Zhang, Yang, Jheon, Sanghoon, Li, Huimin, Zhang, Huibiao, Xie, Yaozeng, Qian, Bin, Lin, Kaihong, Wang, Shengping, Fu, Chen, Hu, Hong, Zheng, Ying, Li, Yuan, Chen, Haiquan

    “…Lung cancer is traditionally more prevalent in the elderly patients, men, and smokers. However, as low-dose computed tomography (LDCT) is increasingly popular,…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Surgical explantation of transcatheter aortic bioprostheses: Results and clinical implications by Fukuhara, Shinichi, Brescia, Alexander A., Shiomi, Suzuna, Rosati, Carlo M., Yang, Bo, Kim, Karen M., Deeb, G. Michael

    “…Despite the rapid adoption of transcatheter aortic valve replacement (TAVR) and worldwide interest in its implantation, TAVR valve explantation has not been…”
    Get full text
    Journal Article
  14. 14

    Managing patients with acute type A aortic dissection and mesenteric malperfusion syndrome: A 20-year experience by Yang, Bo, Norton, Elizabeth L., Rosati, Carlo Maria, Wu, Xiaoting, Kim, Karen M., Khaja, Minhaj S., Deeb, G. Michael, Williams, David M., Patel, Himanshu J.

    “…To assess outcomes of endovascular reperfusion followed by delayed open aortic repair for stable patients with acute type A aortic dissection and mesenteric…”
    Get full text
    Journal Article
  15. 15

    The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients by Priyanka, Priyanka, Zarbock, Alexander, Izawa, Junichi, Gleason, Thomas G., Renfurm, Ronny W., Kellum, John A.

    “…Oliguria after cardiac surgery remains of uncertain clinical significance. Therefore, we investigated the relationship of acute kidney injury severity across…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Hands-on surgical training of congenital heart surgery using 3-dimensional print models by Yoo, Shi-Joon, MD, Spray, Thomas, MD, Austin, Erle H., MD, Yun, Tae-Jin, MD, van Arsdell, Glen S., MD

    “…Abstract Objective Patient-based congenital heart surgery (CHS) training is opportunity-based and difficult. Three-dimensional (3D) print models of the heart…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Gender-related differences in patients with acute aortic dissection type A by Rylski, Bartosz, Georgieva, Nikolina, Beyersdorf, Friedhelm, Büsch, Christopher, Boening, Andreas, Haunschild, Josephina, Etz, Christian D., Luehr, Maximilian, Kallenbach, Klaus

    “…Acute aortic dissection type A can occur in both genders at any age. Our aim was to report differences in presentation, treatment, and outcome in female and…”
    Get full text
    Journal Article
  20. 20

    Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non–small cell lung cancer by Tong, Betty C., Gu, Lin, Wang, Xiaofei, Wigle, Dennis A., Phillips, Joseph D., Harpole, David H., Klapper, Jacob A., Sporn, Thomas, Ready, Neal E., D'Amico, Thomas A.

    “…Pembrolizumab is a programmed death receptor-1 masking antibody approved for metastatic non–small cell lung cancer. This Phase 2 study (NCT02818920) of…”
    Get full text
    Journal Article